Previous 10 | Next 10 |
2023-06-30 11:57:31 ET Abcam ( NASDAQ: ABCM ) ADRs rose 4% on a report that the biotechnology supplier is seeing initial interest from Danaher ( DHR ) and Agilent Technologies ( A ). Abcam ( ABCM ) has also separately reached out to other companies, including G...
Shareholders are encouraged not to attend or submit voting instructions or proxies related to the EGM Abcam plc ("Abcam," "Company," "Group") (Nasdaq: ABCM), a global leader in the supply of life science research tools, today confirmed that it has received a letter of undertaking from D...
2023-06-26 17:01:50 ET Abcam ( NASDAQ: ABCM ) founder Jonathan Milner said he suspended his proxy solicitation effort after the biotech company said Friday it would evaluate strategic alternatives, including a potential sale. Abcam rose 3% in after-hours trading. "In light ...
Abcam plc (“Abcam,” “Company,” “Group”) (Nasdaq: ABCM), a global leader in the supply of life science research tools, today provides the following updates. Although the Company acknowledges that these financial updates are being provided outside our n...
2023-06-23 15:58:25 ET Activist investor Starboard Value said it supports Abcam's ( NASDAQ: ABCM ) announcement that it plans to conduct a strategic review, including a potential sale. "We’re pleased that both Abcam and Jonathan Milner have committed to exploring strategi...
2023-06-23 15:44:06 ET Shares of life sciences company Abcam (NASDAQ: ABCM) were up 13.7% Friday afternoon after rising more than 14.6% earlier in the day. The impetus for the rise was the company's board of directors announcing strategic alternatives that included selling the c...
2023-06-23 10:02:46 ET Gainers: Conformis ( CFMS ) +91% . TRxADE HEALTH ( MEDS ) +11% . Abcam ( ABCM ) +8% . Lexicon Pharmaceuticals ( LXRX ) +4% . Losers: Beyond Air ( XAIR ) -24% . Oramed Pharmaceuticals ( ORMP ) -...
2023-06-23 08:57:30 ET Life sciences firm Abcam ( NASDAQ: ABCM ) rose 11% in premarket trading after saying it would review strategic alternatives after receiving takeover interest. The board, "after having listened to and extensively engaged with shareholders," will immedia...
Abcam Announces Review of Strategic Alternatives PR Newswire CAMBRIDGE, England and WALTHAM, Mass. , June 23, 2023 /PRNewswire/ -- Abcam plc ("Abcam," "Company," "Group") (Nasdaq: ABCM), a global leader in the supply of life science research tools, today anno...
2023-06-20 15:55:45 ET RBC Capital Markets has downgraded Abcam ( NASDAQ: ABCM ) to sector perform, advising investors to take profits from the recent spike in valuation amid takeover speculation. Abcam shares have been on a roll in recent days, fueled by a board battle with the...
News, Short Squeeze, Breakout and More Instantly...
Danaher Completes Acquisition of Abcam PR Newswire WASHINGTON , Dec. 6, 2023 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) ("Danaher") announced today it has completed its acquisition of Abcam plc (NASDAQ:ABCM) ("Abcam"). The acquisition of Abcam for $24.0...
Abcam plc (Nasdaq: ABCM) (‘Abcam’, the ‘Group’ or the ‘Company’), a global leader in the supply of life science research tools, entered into a definitive agreement on August 26, 2023 relating to its proposed acquisition by Danaher Corporation (NYSE: DHR) ...
2023-11-19 06:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...